Regencell Bioscience Holdings annual operating expenses
2019
2020
2021
2022
2023
2024
2025
Regencell Bioscience Holdings Operating Expenses Growth & History (RGC)
Regencell Bioscience Holdings's operating expenses was $3.8M for fiscal 2025.
View full Regencell Bioscience Holdings company overviewRegencell Bioscience Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $3.8M | −$966,741 | −20.41% |
| 2024 | 2024-06-30 | $4.7M | −$1.5M | −24.50% |
| 2023 | 2023-06-30 | $6.3M | −$1.3M | −17.64% |
| 2022 | 2022-06-30 | $7.6M | $6.2M | +451.47% |
| 2021 | 2021-06-30 | $1.4M | $568,991 | +70.04% |
| 2020 | 2020-06-30 | $812,371 | $421,381 | +107.77% |
| 2019 | 2019-06-30 | $390,990 | — | — |
Regencell Bioscience Holdings operating expenses trends
Over the last five fiscal years, Regencell Bioscience Holdings's operating expenses increased from $812,371 to $3.8M, a change of $3.0M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regencell Bioscience Holdings source filings ↗